Physician profile
Thomas P Wolfe
NPI 1891831665
$2,662.16
in general payments reported to CMS, 2019-2025
28 companies · $500 in 2025
The $500 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $67.90 · 2021: $315 · 2022: $530 · 2023: $468 · 2024: $552 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.60 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $400.79 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $363.86 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Abbvie INC. | $363.64 | 2019-2025 | Liletta |
| Coopersurgical, INC. | $292.60 | 2019-2025 | Endosee, Paragard T 380a |
| Mayne Pharma Commercial LLC | $203.52 | 2021-2025 | |
| Biogen, INC. | $160.15 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $148.97 | 2022-2024 | |
| Daiichi Sankyo INC. | $144.50 | 2019-2024 | Injectafer |
| Organon LLC | $97.30 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $90.88 | 2019-2025 | Slynd |
| Intuitive Surgical, INC. | $73.57 | 2021 | |
| Medtronic, INC. | $38.17 | 2022 | |
| Lupin INC. | $28.77 | 2019 | |
| Merck Sharp & Dohme LLC | $26.19 | 2019 | |
| Shield Therapeutics INC | $23.29 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $21.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.76 | 2020 | |
| Ethicon US, LLC | $18.13 | 2024 | Vistaseal, Surgicel Nu-Knit, Enseal |
| Exact Sciences Corporation | $18.01 | 2025 | Cologuard Collection Kit |
| Millicent US INC | $17.51 | 2024 | Intrarosa, Femring |
| Meditrina | $15.90 | 2024 | |
| Aspira Women'S Health INC | $15.86 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.61 | 2022 | |
| Avion Pharmaceuticals | $14.40 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.77 | 2019 | |
| Sumitomo Pharma America, INC. | $12.90 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $12.68 | 2019 | |
| Allergan, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.